Literature DB >> 18617201

Effect of physician strategies for coping with the US medical malpractise crisis on healthcare delivery and patient access to healthcare.

G D Dalton1, X F Samaropoulos, A C Dalton.   

Abstract

The medical liability system in the USA is once again mired in a major malpractise crisis. Physicians have struggled to acquire liability coverage during the crisis, because malpractise insurance has been unaffordable and unavailable. This limited access to affordable liability coverage has prompted some physicians to utilize strategies that reduce their malpractise risk. These strategies have included eliminating high-risk services, defensive medicine, and establishing medical practises in states with affordable malpractise insurance. The fear of malpractise liability and possible financial ruin may justify the use of these strategies. However, these tactics could create a serious public health problem, because they are having a negative impact on healthcare delivery and patient access to healthcare.

Entities:  

Mesh:

Year:  2008        PMID: 18617201     DOI: 10.1016/j.puhe.2008.01.010

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  3 in total

1.  Triggers of defensive medical behaviours: a cross-sectional study among physicians in the Netherlands.

Authors:  Erik Renkema; Kees Ahaus; Manda Broekhuis; Maria Tims
Journal:  BMJ Open       Date:  2019-06-25       Impact factor: 2.692

2.  Conditions that influence the impact of malpractice litigation risk on physicians' behavior regarding patient safety.

Authors:  Erik Renkema; Manda Broekhuis; Kees Ahaus
Journal:  BMC Health Serv Res       Date:  2014-01-25       Impact factor: 2.655

3.  Spine neurosurgeons facing the judicialization of their profession: disenchantment and alteration of daily practice-a qualitative study.

Authors:  Antoine Guillain; Anne-Hélène Moncany; Olivier Hamel; Carole Gerson; Renaud Bougeard; Grégory Dran; Bertrand Debono
Journal:  Acta Neurochir (Wien)       Date:  2020-03-27       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.